2,704
Views
10
CrossRef citations to date
0
Altmetric
State Of The Art Reviews

Physiopathological approach to infective endocarditis in chronic hemodialysis patients: left heart versus right heart involvement

Pages 432-439 | Received 13 Jan 2017, Accepted 07 Mar 2017, Published online: 24 Mar 2017

References:

  • Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966;275:1089–1092.
  • USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2012.
  • Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154–2169.
  • Abbott KC, Agodoa LY. Hospitalizations for bacterial endocarditis after initiation of chronic dialysis in the United States. Nephron 2002;91:203–209.
  • Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: Results of a 1-year survey in France. JAMA 2002;288:75–81.
  • Maraj S, Jacobs LE, Kung S-C, et al. Epidemiology and outcome of infective endocarditis in hemodialysis patients. Am J Med Sci 2002; 324:254–260.
  • Leonard A, Raij L, Shapiro FL. Bacterial endocarditis in regularly dialyzed patients. Kidney Int 1973;4:407–422.
  • Kamalakannan D, Pai RM, Johnson LB, Gardin JM, Saravolatz LD. Epidemiology and clinical outcomes of infective endocarditis in hemodialysis patients. Ann Thorac Surg 2007;83:2081–2086.
  • Kessler M, Hoen B, Mayeux D, Hestin D, Fontenaille C. Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey. Nephron 1993;64:95–100.
  • Haag-Weber M, Hörl WH. Uremia and infection: mechanisms of impaired cellular host defense. Nephron 1993;63:125–131.
  • Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002;39:695–701.
  • Doulton T, Sabharwal N, Cairns HS, et al. Infective endocarditis in dialysis patients: new challenges and old. Kidney Int 2003;64:720–727.
  • Hanslik T, Flahault A, Vaillant JN, et al. High risk of severe endocarditis in patients on chronic dialysis. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc – Eur Ren Assoc 1997;12:1301–1302.
  • Rekik S, Trabelsi I, Hentati M, et al. Infective endocarditis in hemodialysis patients: Clinical features, echocardiographic data and outcome: A 10-year descriptive analysis. Clin Exp Nephrol 2009;13:350–354.
  • Nori US, Manoharan A, Thornby JI, Yee J, Parasuraman R, Ramanathan V. Mortality risk factors in chronic haemodialysis patients with infective endocarditis. Nephrol Dial Transplant 2006;21:2184–2190.
  • Oun HA, Price AJ, Traynor JP. Infective endocarditis in patients on haemodialysis – Possible strategies for prevention. Scott Med J 2016;61:97–102.
  • Krcmery V, Kisac P. Bacterial endocarditis in haemodialysis patients. Is frequent heparinisation protecting embolisation? Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 2011;30:1627–1628.
  • Spies C, Madison JR, Schatz IJ. Infective endocarditis in patients with end-stage renal disease: Clinical presentation and outcome. Arch Intern Med 2004;164:71–75.
  • Robinson DL, Fowler VG, Sexton DJ, Corey RG, Conlon PJ. Bacterial endocarditis in hemodialysis patients. Am J Kidney Dis Off J Natl Kidney Found 1997;30:521–524.
  • Chang C-F, Kuo BI-T, Chen T-L, Yang W-C, Lee S-D, Lin C-C. Infective endocarditis in maintenance hemodialysis patients: Fifteen years’ experience in one medical center. J Nephrol 2004;17:228–235.
  • Fernández-Cean J, Alvarez A, Burguez S, Baldovinos G, Larre-Borges P, Cha M. Infective endocarditis in chronic haemodialysis: Two treatment strategies. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc – Eur Ren Assoc 2002;17:2226–2230.
  • Jones DA, McGill L-A, Rathod KS, et al. Characteristics and outcomes of dialysis patients with infective endocarditis. Nephron Clin Pract 2013;123:151–156.
  • Maher ER, Young G, Smyth-Walsh B, Pugh S, Curtis JR. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet Lond Engl 1987;2:875–877.
  • Straumann E, Meyer B, Misteli M, Blumberg A, Jenzer HR. Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis. Br Heart J 1992;67:236–239.
  • Michel PL. Aortic stenosis in chronic renal failure patients treated by dialysis. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc – Eur Ren Assoc 1998;13:44–48.
  • Fox CS, Larson MG, Vasan RS, et al. Cross-sectional association of kidney function with valvular and annular calcification: The Framingham heart study. J Am Soc Nephrol JASN 2006;17:521–527.
  • Leskinen Y, Paana T, Saha H, et al. Valvular calcification and its relationship to atherosclerosis in chronic kidney disease. J Heart Valve Dis 2009;18:429–438.
  • Ikee R, Honda K, Oka M, et al. Association of heart valve calcification with malnutrition-inflammation complex syndrome, beta-microglobulin, and carotid intima media thickness in patients on hemodialysis. Ther Apher Dial Off Peer-Rev J Int Soc Apher Jpn Soc Apher Jpn Soc Dial Ther 2008;12:464–468.
  • Sharma R, Pellerin D, Gaze DC, et al. Mitral annular calcification predicts mortality and coronary artery disease in end stage renal disease. Atherosclerosis 2007;191:348–354.
  • Kraus MA, Kalra PA, Hunter J, Menoyo J, Stankus N. The prevalence of vascular calcification in patients with end-stage renal disease on hemodialysis: A cross-sectional observational study. Ther Adv Chronic Dis 2015;6:84–96.
  • Fernandez-Reyes MJ, Auxiliadora Bajo M, Robles P, et al. Mitral annular calcification in CAPD patients with a low degree of hyperparathyroidism. An analysis of other possible risk factors. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc – Eur Ren Assoc 1995;10:2090–2095.
  • Holick MF, Krane SM, Potts JT, Calcium, phosphorus and bone metabolism: Calcium regulating hormones. In: Fauci AS, ed. Harrison’s Principles of Internal Medicine, 14th ed. New York: Mc Graw-Hill; 1998:2214–2227.
  • Wang AY-M, Woo J, Lam CW-K, et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc – Eur Ren Assoc 2005;20:1676–1685.
  • Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet Lond Engl 2003;361:827–833.
  • Mohler ER, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001;103:1522–1528.
  • Carrero JJ, Stenvinkel P. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: A hypothesis proposal. Clin J Am Soc Nephrol CJASN 2009;4:S49–S55.
  • Mazzaferro S, Coen G, Bandini S, et al. Role of ageing, chronic renal failure and dialysis in the calcification of mitral annulus. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc – Eur Ren Assoc 1993;8:335–340.
  • Deutscher S, Rockette HE, Krishnaswami V. Diabetes and hypercholesterolemia among patients with calcific aortic stenosis. J Chronic Dis 1984;37:407–415.
  • Braunwald E, Valvular heart disease. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine, 5th ed. Philadelphia: Saunders; 1997:1035–1048.
  • Ureña P, Malergue MC, Goldfarb B, Prieur P, Guédon-Rapoud C, Pétrover M. Evolutive aortic stenosis in hemodialysis patients: Analysis of risk factors. Nephrologie 1999;20:217–225.
  • Nestico PF, Depace NL, Morganroth J, Kotler MN, Ross J. Mitral annular calcification: Clinical, pathophysiology, and echocardiographic review. Am Heart J 1984;107:989–996.
  • Minnaganti VR, Cunha BA. Infections associated with uremia and dialysis. Infect Dis Clin North Am 2001;15:385–406, viii.
  • Hauser AB, Stinghen AEM, Kato S, et al. Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int J Int Soc Perit Dial 2008;28:S183–S187.
  • Vascular Access 2006 Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis Off J Natl Kidney Found 2006;48:S176–S247.
  • Taylor G, Gravel D, Johnston L, et al. Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control 2004;32:155–160.
  • Allon M, Daugirdas J, Depner TA, Greene T, Ornt D, Schwab SJ. Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis Off J Natl Kidney Found 2006;47:469–477.
  • Lemaire X, Morena M, Leray-Moragués H, et al. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis. Blood Purif 2009;28:21–28.
  • Oliver MJ, Callery SM, Thorpe KE, Schwab SJ, Churchill DN. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: A prospective study. Kidney Int 2000;58:2543–2545.
  • Stevenson KB, Hannah EL, Lowder CA, et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: Predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis Off J Natl Kidney Found 2002;39:549–555.
  • Chan MR. Hemodialysis central venous catheter dysfunction. Semin Dial 2008;21:516–521.
  • Garnacho-Montero J, Aldabó-Pallás T, Palomar-Martínez M, et al. Risk factors and prognosis of catheter-related bloodstream infection in critically ill patients: A multicenter study. Intensive Care Med 2008;34:2185–2193.
  • Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis Off J Natl Kidney Found 2004;44:779–791.
  • Mokrzycki MH, Zhang M, Cohen H, Golestaneh L, Laut JM, Rosenberg SO. Tunnelled haemodialysis catheter bacteraemia: Risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc – Eur Ren Assoc 2006;21:1024–1031.
  • Ashby DR, Power A, Singh S, et al. Bacteremia associated with tunneled hemodialysis catheters: Outcome after attempted salvage. Clin J Am Soc Nephrol CJASN 2009;4:1601–1605.
  • Durante-Mangoni E, Pafundi PC, Ravasio V, et al. Current features of infective endocarditis in persons on hemodialysis: A prevalence study with case control design from the prospective multicenter SEI cohort. Infection 2016;44:467–474.
  • Musci M, Siniawski H, Pasic M, et al. Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg 2007;32:118–125.
  • Mi MY, Nelson SB, Weiner RB. Clinical and echocardiographic factors associated with in-hospital mortality in patients with infective endocarditis affecting the native tricuspid valve. Am J Cardiol 2016;118:739–743.
  • Jiang S, Li B, Zhang T, et al. Surgical treatment of isolated right-sided infective endocarditis. Tex Heart Inst J 2011;38:639–642.
  • Dawood MY, Cheema FH, Ghoreishi M, et al. Contemporary outcomes of operations for tricuspid valve infective endocarditis. Ann Thorac Surg 2015;99:539–546.
  • Moss R, Munt B. Injection drug use and right sided endocarditis. Heart Br Card Soc 2003;89:577–581.
  • McCarthy JT, Steckelberg JM. Infective endocarditis in patients receiving long-term hemodialysis. Mayo Clin Proc 2000;75:1008–1014.
  • Bentata Y, Haddiya I, Ismailli N, et al. Infective endocarditis in chronic hemodialysis: A transition from left heart to right heart? Saudi J Kidney Dis Transpl 2016;27:1200–1206.
  • Chambers HF, Morris DL, Täuber MG, Modin G. Cocaine use and the risk for endocarditis in intravenous drug users. Ann Intern Med 1987;106:833–836.
  • Jain V, Yang M-H, Kovacicova-Lezcano G, Juhle LS, Bolger AF, Winston LG. Infective endocarditis in an urban medical center: Association of individual drugs with valvular involvement. J Infect 2008;57:132–138.
  • Crane LR, Levine DP, Zervos MJ, Cummings G. Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy. Rev Infect Dis 1986;8:364–373.
  • Miró JM, del Río A, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin 2003;21:167–184.
  • Sullam PM, Drake TA, Sande MA. Pathogenesis of endocarditis. Am J Med 1985;78:110–115.
  • Revilla A, López J, Villacorta E, et al. Isolated right-sided valvular endocarditis in non-intravenous drug users. Rev Esp Cardiol 2008;61:1253–1259.
  • Baroudi S, Qazi RA, Lentine KL, Bastani B. Infective endocarditis in haemodialysis patients: 16-year experience at one institution. NDT Plus 2008;1:253–256.
  • Bolignano D, Rastelli S, Agarwal R, et al. Pulmonary hypertension in CKD. Am J Kidney Dis 2013;61:612–622.
  • Sise ME, Courtwright AM, Channick RN. Pulmonary hypertension in patients with chronic and end-stage kidney disease. Kidney Int 2013;84:682–692.
  • Nadji G, Rémadi JP, Coviaux F, et al. Comparison of clinical and morphological characteristics of Staphylococcus aureus endocarditis with endocarditis caused by other pathogens. Heart Br Card Soc 2005;91:932–937.
  • Takahashi C, Warrak EA, Ruzany F. Infectious endocarditis in patients on periodic hemodialysis. AMB Rev Assoc Med Bras 1991;37:119–126.
  • Tao J-L, Ma J, Ge G-L, et al. Diagnosis and treatment of infective endocarditis in chronic hemodialysis patients. Chin Med Sci J Chung-Kuo Hsüeh Ko Hsüeh Tsa Chih Chin Acad Med Sci 2010; 25:135–139.
  • Ludvigsen LU, Dalgaard LS, Wiggers H, et al. Infective endocarditis in patients receiving chronic hemodialysis: A 21-year observational cohort study in Denmark. Am Heart J 2016;182:36–43.
  • Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994;96: 200–209.